Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. mPEG-OPSS is also called mPEG-PDP, PDP: 3-(2-pyridyldithio) propionic acid.
Target
mPEG-OPSS
Form
Solid
Purity
≥ 95% (1H-NMR). Product conforms to structure by 1H-NMR.
Storage
Store between 0 and -5 °C. Avoid exposure to light. Ensure the vial lid is sealed when not in use.
Availability
Shipped within 7-15 working days.
Note
This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.
We use cookies necessary for the function of our website, to improve your experience, analyse our traffic, and cookies that optimise the performance. To learn more about our cookies, please read our Cookie Notice.